REFRACTORY GLIOBLASTOMA

Clinical trials for REFRACTORY GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for REFRACTORY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3

Experimental CAR-T therapy targets deadly brain tumors in first human trial

Disease control Recruiting now

This early-phase trial tests a new treatment called EPC-003, which uses specially engineered immune cells (CAR-T cells) to target two proteins found on glioblastoma cells. About 14 adults with recurrent or refractory glioblastoma will receive the therapy directly into the brain's…

Matched conditions: REFRACTORY GLIOBLASTOMA

Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

REFRACTORY GLIOBLASTOMA

Get alerted when new REFRACTORY GLIOBLASTOMA trials appear

Experimental CAR-T therapy targets deadly brain tumors in first human trial